Digital Therapeutics Sarcopenia Market to Reach $2.77 Billion by 2029, Growing at a CAGR of 16%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Digital Therapeutics Sarcopenia Industry In 2025?

The digital therapeutics sarcopenia market size has experienced significant expansion in recent years. It is anticipated to grow from $1.32 billion in 2024 to $1.54 billion in 2025, reflecting a compound annual growth rate (CAGR) of 16.3%. The growth observed in previous periods stems from a rising aging population, the increasing occurrence of age-related muscle loss, greater awareness of sarcopenia, an increase in telehealth adoption, growing demand for home-based rehabilitation, and supportive government initiatives favoring digital healthcare.

The digital therapeutics sarcopenia market is projected to experience substantial expansion over the coming years, reaching a valuation of $2.78 billion by 2029, with an impressive compound annual growth rate (CAGR) of 16.0%. This anticipated market surge is primarily driven by factors such as an expanding elderly demographic, a heightened emphasis on maintaining muscle health proactively, the increasing incorporation of artificial intelligence within digital therapeutics, broader reimbursement frameworks for DTx, the creation of tailored exercise regimens, burgeoning collaborations between technology enterprises and healthcare providers, and a rising need for remote rehabilitation services. Prominent developments expected during this period encompass enhancements in AI-powered personalized exercise routines, seamless integration with wearable health monitoring devices, the proliferation of tele-rehabilitation platforms, greater adoption within senior care settings, improved remote patient monitoring functionalities, and overall progress in digital health solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Digital Therapeutics Sarcopenia Industry?

The escalating occurrence of comorbidities is poised to drive the expansion of the digital therapeutics sarcopenia market in the future. Comorbidities denote the simultaneous existence of multiple health conditions within a single person. Their increase is attributable to the world’s aging demographic, as advancing age heightens the probability of developing several chronic conditions due to diminishing physiological function and extended exposure to various health hazards. Digital therapeutics designed for sarcopenia prove beneficial in averting comorbidities, especially obesity, by fostering regular physical exercise and muscle development, which in turn enhance metabolism and mitigate fat accumulation. For instance, in March 2024, data from the World Obesity Federation, a UK-based membership organization, indicated that close to 79% of adults affected by overweight and obesity are projected to live in low- and middle-income nations by the year 2035, with the global count of adults with obesity expected to climb to 1.53 billion. Consequently, the rising prevalence of comorbidities is propelling the growth of the digital therapeutics sarcopenia market.

How Is The Digital Therapeutics Sarcopenia Market Classified Into Different Segments?

The digital therapeutics sarcopenia market covered in this report is segmented

1) By Product: Software, Devices, Services

2) By Distribution Channel: Online Platforms, Pharmacies, Other Distribution Channels

3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications

4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users

Subsegments:

1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software

2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools

3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services

What Trends Are Expected To Drive The Digital Therapeutics Sarcopenia Market?

Leading companies in the digital therapeutics sarcopenia market are focusing on developing advanced solutions, such as drug discovery platforms, to create more targeted therapies, enhance treatment effectiveness, and accelerate the provision of personalized care for age-related muscle loss. A drug discovery platform assists in finding and creating new drugs faster and more effectively by using advanced tools and methods. For instance, in April 2025, ProFuse Technology, an Israel-based biotechnology firm, launched a novel drug discovery platform aimed at preventing muscle loss caused by GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. Utilizing lab-grown, highly mature muscle tissues that imitate natural muscle, the company can accurately test and screen drug candidates more quickly and efficiently. This advanced platform reduces dependence on animal testing and lowers research costs. As therapies focused on muscle preservation become more sought after, ProFuse is expanding beyond cultivated meat into biopharma, offering a groundbreaking approach to address growing muscle health challenges.

Who Are The Prominent Global Companies Shaping The Digital Therapeutics Sarcopenia Market?

Major companies operating in the digital therapeutics sarcopenia market are Noom Inc., Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Virta Health Corp., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Propeller Health, Lark Technologies Inc., mySugr GmbH, SilverCloud Health Limited (a part of Amwell), Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, and Cometa Srl.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/digital-therapeutics-sarcopenia-global-market-report

How Do Regional Market Performances Compare Within The Digital Therapeutics Sarcopenia Industry?

North America was the largest region in the digital therapeutics sarcopenia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Digital Therapeutics Sarcopenia Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27278&type=smp

Browse Through More Reports Similar to the Global Digital Therapeutics Sarcopenia Market 2025, By The Business Research Company

Lithium Ion Battery Binders Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lithium-ion-battery-binders-global-market-report

Cutter Stapler Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cutter-stapler-global-market-report

Battery Manufacturing Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/battery-manufacturing-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795